Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL823100 | 0.72 | HTR1A (0.36) | HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL11573609 | 0.69 | — | — | |
| SCHEMBL23019835 | 0.67 | HTR1A (0.33) | HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL7247165 | 0.67 | HTR1A (0.33) | HTR1ADRD2HTR2AHTR7 | |
| Fluoride SCHEMBL775570 | 0.65 | HTR1A (0.32) | HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL5494090 | 0.65 | — | — | |
| SCHEMBL22484531 | 0.65 | — | — | |
| SCHEMBL21190314 | 0.65 | HTR1A (0.32) | HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL2517119 | 0.63 | HTR1A (0.31) | HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL3391323 | 0.62 | HTR1A (0.56) | HTR1ADRD2HTR2AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9497970-B2 | Pesticide compounds | BASF SE (DE) | 2016-11-22 | — | — | US | disclosed |
| US-20160157491-A1 | Pesticide Compounds | BASF SE (DE) | 2016-06-09 | — | — | US | disclosed |
| US-9174967-B2 | Substituted pyrazole-containing compounds and their use as pesticides | BASF SE (DE) | 2015-11-03 | — | — | US | disclosed |
| US-9169253-B2 | Tricyclic quinoline and quinoxaline derivatives | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-10-27 | — | — | US | disclosed |
| US-20150250175-A1 | PESTICIDALLY ACTIVE MIXTURES COMPRISING ANTHRANILAMIDE COMPOUNDS | BASF SE (DE) | 2015-09-10 | — | — | US | disclosed |
| US-20150250173-A1 | PESTICIDALLY ACTIVE MIXTURES COMPRISING ANTHRANILAMIDE COMPOUNDS | BASF SE (DE) | 2015-09-10 | — | — | US | disclosed |
| US-20150237858-A1 | METHOD OF CONTROLLING RYANODINE-MODULATOR INSECTICIDE RESISTANT INSECTS | BASF SE (DE) | 2015-08-27 | — | — | US | disclosed |
| US-9096583-B2 | Substituted 1,2,5-oxadiazole compounds and their use as herbicides II | BASF SE (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9044016-B2 | N-thio-anthranilamide compounds and their use as pesticides | BASF SE (DE) | 2015-06-02 | — | — | US | disclosed |
| US-20150065343-A1 | Acrylamide compounds for combating invertebrate pests | BASF SE (DE) | 2015-03-05 | — | — | US | disclosed |
| US-20110021486-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-01-27 | — | — | US | disclosed |
| EP-2019825-B9 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INT (DE) | 2011-01-26 | — | — | EP | disclosed |
| US-20110015203-A1 | Viral Polymerase Inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| US-20100075944-A1 | NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3) | MATSUSHIMA TOMOHIRO | 2010-03-25 | — | — | US | disclosed |
| US-20090312272-A1 | Transglutaminase inhibitors and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY; AND THE WASHINGTON UNIVERSITY | 2009-12-17 | — | — | US | disclosed |
| US-7528173-B2 | Plasma carboxypeptidase B inhibitors | SCHERING AKTIENGESELLSHAFT (DE) | 2009-05-05 | — | — | US | disclosed |
| US-7393869-B2 | Methods of using thiazolidine derivatives to treat cancer or inflammation | QLT INC. (CA) | 2008-07-01 | — | — | US | disclosed |
| US-20060247213-A1 | Plasma carboxypeptidase b inhibitors | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-11-02 | — | — | US | disclosed |
| US-20060234986-A1 | Use of TAFI inhibitors for enhanced myocardial reperfusion and facilitated PCI | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-10-19 | — | — | US | disclosed |
| US-20060183782-A1 | Methods of using thiazolidine derivatives to treat cancer or inflammation | QLT INC. (CA) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160157491-A1 | Pesticide Compounds | C1R, C1S, CBR3 | HTR1A 1326/4885DRD2 346/4885HTR2A 2883/4885 |
| US-20150250173-A1 | PESTICIDALLY ACTIVE MIXTURES COMPRISING ANTHRANILAMIDE COMPOUNDS | AADAC, ARSA, SIRT7 | HTR1A 4811/4885DRD2 3215/4885HTR2A 4813/4885 |
| US-20060183782-A1 | Methods of using thiazolidine derivatives to treat cancer or inflammation | PTPN2, PTPRCAP, PTPN5 | HTR1A 4379/4885DRD2 4846/4885HTR2A 3000/4885 |
| US-20150065343-A1 | Acrylamide compounds for combating invertebrate pests | AAAS, ACR, ATL3 | HTR1A 1241/4885DRD2 2066/4885HTR2A 957/4885 |
| US-20100075944-A1 | NOVEL PYRIDINE DERIVATIVES AND PYRIMIDINE DERIVATIVES (3) | HGF, MET, HDGF | HTR1A 1711/4885DRD2 1703/4885HTR2A 3492/4885 |
| US-20150250175-A1 | PESTICIDALLY ACTIVE MIXTURES COMPRISING ANTHRANILAMIDE COMPOUNDS | MCU, AGK, MLYCD | HTR1A 2953/4885DRD2 3109/4885HTR2A 1701/4885 |
| US-20060234986-A1 | Use of TAFI inhibitors for enhanced myocardial reperfusion and facilitated PCI | TFPI, TFPI2, TNNI3 | HTR1A 2147/4885DRD2 4547/4885HTR2A 2373/4885 |
| US-20110021486-A1 | VIRAL POLYMERASE INHIBITORS | POLR2A, POLR2B, POLR2H | HTR1A 3378/4885DRD2 3199/4885HTR2A 4345/4885 |
| US-20060247213-A1 | Plasma carboxypeptidase b inhibitors | CPB1, CPB2, CPA1 | HTR1A 1818/4885DRD2 4346/4885HTR2A 2940/4885 |
| US-20110015203-A1 | Viral Polymerase Inhibitors | POLR2A, POLR1E, RPP30 | HTR1A 3926/4885DRD2 2723/4885HTR2A 4542/4885 |
| US-20150237858-A1 | METHOD OF CONTROLLING RYANODINE-MODULATOR INSECTICIDE RESISTANT INSECTS | RYR2, RYR1, CRY1 | HTR1A 2051/4885DRD2 1711/4885HTR2A 1774/4885 |
| US-20090312272-A1 | Transglutaminase inhibitors and methods of use thereof | TGM2, TGM3, TGM1 | HTR1A 3595/4885DRD2 4884/4885HTR2A 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.